Ultrasound-triggered drug delivery

Ultrasound-triggered drug delivery is a non-invasive approach that uses acoustic energy to achieve spatially localized drug release. The mechanism relies on gas-filled microbubbles or other ultrasound-responsive carriers that physically oscillate when exposed to ultrasound waves. These oscillations generate mechanical forces that can temporarily disrupt cell membranes (sonoporation), enhance vascular permeability, and trigger the release of therapeutic agents from specialized carriers. The technology employs various types of carriers including microbubbles (1-10 μm), submicron bubbles, liposomes, micelles, and phase-change agents. When these carriers are exposed to focused ultrasound, several physical effects occur: cavitation (stable or inertial), microstreaming, radiation forces, and localized hyperthermia. These effects can be precisely controlled by adjusting ultrasound parameters such as frequency, pressure amplitude, pulse duration, and mechanical index. A significant advantage of this approach is the ability to deliver therapeutics only to targeted areas while minimizing systemic exposure and side effects. The drug carriers circulate harmlessly throughout the body but release their payload only where ultrasound is applied. This technology has shown particular promise for crossing difficult biological barriers such as the blood-brain barrier, enhancing chemotherapy delivery to tumors, and enabling transdermal delivery of large molecules like insulin and other proteins.

Other names

Ultrasound-mediated drug deliverySonoporation-based drug deliveryMicrobubble-enhanced ultrasound drug deliveryAcoustic-triggered drug release

Acoustic cavitation of microbubbles causing temporary disruption of cell membranes. Thermal effects inducing release from temperature-sensitive carriers. Mechanical forces (microstreaming, radiation forces) disrupting drug carriers. Vaporization of perfluorocarbon droplets in response to ultrasound. Shear stress-induced membrane permeabilization.